2 Followers on Owler

Terns

is a California-based clinical-stage biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of cancer and obesity... Read more
OverviewCompetitorsFundingNews & Insights

Terns

is a California-based clinical-stage biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of cancer and obesity... Read more
Terns CEO: Amy Burroughs

CEO

Amy Burroughs

CEO Approval Rating

86/100

2017

PublicIndependent CompanyNASDAQTERN

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
2836 NAICS listing

Annual Revenue
$ < 1M
Employees
40
Funding
$648.5M

News

Conference Presentation
Jan 08, 2025
Marketscreener
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
Funding
Sep 13, 2024
GlobalNewswire
Terns received $172.7M in Post-IPO Equity Funding

Terns Competitors

1Agenus
2Inovio
3Kite Pharma
4Amgen
5Intercept
6Enanta
7Viking
8Novartis
9Novo Nordisk
10Merck
Unlock 28 + competitors

Trending Companies